Covered recipient · General Payments record
MARY LELA VONDER HAAR
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$894.90
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $373.27 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $175.93 | 7 |
| Astellas Pharma US Inc | $56.40 | 3 |
| BECTON, DICKINSON AND COMPANY | $43.84 | 1 |
| Amgen Inc. | $32.66 | 2 |
| Hologic Sales and Service, LLC | $21.34 | 1 |
| Exeltis, USA Inc. | $15.49 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $14.37 | 1 |
| Daiichi Sankyo Inc. | $13.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.09 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117408307 | CMS |
| Amgen Inc. | $18.57 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117408309 | CMS |
| Astellas Pharma US Inc | $17.77 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139481998 | CMS |
| Astellas Pharma US Inc | $23.63 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139543104 | CMS |
| Astellas Pharma US Inc | $15.00 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139556207 | CMS |
| Becton, Dickinson and Company | $43.84 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127617601 | CMS |
| Biogen, Inc. | $29.51 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104865066 | CMS |
| Biogen, Inc. | $18.58 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104822430 | CMS |
| Biogen, Inc. | $25.08 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104867320 | CMS |
| Biogen, Inc. | $25.08 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104837864 | CMS |
| Biogen, Inc. | $25.08 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104832620 | CMS |
| Biogen, Inc. | $25.08 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104845526 | CMS |
| Biogen, Inc. | $27.52 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104854676 | CMS |
| Daiichi Sankyo Inc. | $13.24 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089495460 | CMS |
| Exeltis, USA Inc. | $15.49 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150020995 | CMS |
| Hologic Sales and Service, LLC | $21.34 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084899908 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $14.37 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154686615 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.